Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
MEDICATION PREFERENCES OF MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME (ME/CFS) PATIENTS
- At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
- Type: Poster
- By: ARAJA, Diana (Latvia)
- Co-author(s): Diana Araja: Riga Stradins University, Riga, Latvia
Elenka Brenna: Università Cattolica del Sacro Cuore, Rome, Italy
Derek Pheby: Buckinghamshire New University, London, United Kingdom
Uldis Berķis: Riga Stradins University, Riga, Latvia
Asja Lunga: Riga Stradins University, Riga, Latvia
Modra Murovska: Riga Stradins University, Riga, Latvia
BackgroundMyalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a multi-system disorder, which lead to substantial reductions in functional activity and quality of life. There are no Europe-wide prevalence data, but it is estimated that there are some two million sufferers in Europe as a whole.
MethodsTo achieve the goal of this research,.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 13 May 2019